GeNeuro Statistics
Total Valuation
GeNeuro has a market cap or net worth of EUR 2.07 million. The enterprise value is 13.91 million.
Market Cap | 2.07M |
Enterprise Value | 13.91M |
Important Dates
The next estimated earnings date is Friday, May 2, 2025.
Earnings Date | May 2, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
GeNeuro has 29.60 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 29.60M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -0.07% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 2.76% |
Float | 6.77M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -0.15 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.94 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -1.37 |
Financial Position
The company has a current ratio of 0.37
Current Ratio | 0.37 |
Quick Ratio | 0.29 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -1.35 |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -100.64% |
Return on Invested Capital (ROIC) | -211.83% |
Return on Capital Employed (ROCE) | -12,773.40% |
Revenue Per Employee | n/a |
Profits Per Employee | -868,059 |
Employee Count | 17 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.10% in the last 52 weeks. The beta is 0.73, so GeNeuro's price volatility has been lower than the market average.
Beta (5Y) | 0.73 |
52-Week Price Change | -95.10% |
50-Day Moving Average | 0.09 |
200-Day Moving Average | 0.09 |
Relative Strength Index (RSI) | 47.00 |
Average Volume (20 Days) | 58,273 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -14.36M |
Pretax Income | -14.75M |
Net Income | -14.76M |
EBITDA | -14.32M |
EBIT | -14.36M |
Earnings Per Share (EPS) | -0.59 |
Balance Sheet
The company has 1.83 million in cash and 13.67 million in debt, giving a net cash position of -11.84 million or -0.40 per share.
Cash & Cash Equivalents | 1.83M |
Total Debt | 13.67M |
Net Cash | -11.84M |
Net Cash Per Share | -0.40 |
Equity (Book Value) | -13.78M |
Book Value Per Share | -0.55 |
Working Capital | -3.92M |
Cash Flow
In the last 12 months, operating cash flow was -10.15 million and capital expenditures -12,500, giving a free cash flow of -10.16 million.
Operating Cash Flow | -10.15M |
Capital Expenditures | -12,500 |
Free Cash Flow | -10.16M |
FCF Per Share | -0.34 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
GeNeuro does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.96% |
Shareholder Yield | -3.96% |
Earnings Yield | -712.30% |
FCF Yield | -490.39% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |